AI MARKET SCANNING

MannKind Corp

📅 Next Catalyst: Nov 04, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.84%
MAX GAP RECORD +8.76%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MNKD
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
-6.83%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
-6.74%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
+5.71%
Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN)
+8.76%
Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN)
-8.02%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-4.95%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.8%
Bullish Gaps (7)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MNKD

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗